Bimekizumab population pharmacokinetic and exposure-response analyses in adults with moderate to severe hidradenitis suppurativa ACoP15 (Nov 2024), Poster: T-041 Jönsson S, Gallais F, Janssen JM, Rolleri R, Khandelwal A, Dua P, Sidhu J. ConferenceInflammationPharmacometricsProgram strategies and efficiencies Pharmetheus Affiliates Senior Consultant, R&D Scientist Siv Jönsson See bio Consultant Fanny Gallais See bio Consultant Julie Janssen See bio Quality Control and Medical Writer Viviana Moroso See bio